Transporters for the intestinal absorption of cholesterol, vitamin E, and vitamin K

Journal of Atherosclerosis and Thrombosis

Volumn 24, Issue 4, 2017, Pages 347-359

  Yamanashi, Yoshihide ^a   Takada, Tappei ^a   Kurauchi, Ryoya ^a   Tanaka, Yusuke ^a   Komine, Toko ^a   Suzuki, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

ABCA1; CD36; Ezetimibe; NPC1L1; SR BI

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G5; ABC TRANSPORTER G8; ALPHA TOCOPHEROL; CD36 ANTIGEN; CHOLESTEROL; EZETIMIBE; LOW DENSITY LIPOPROTEIN; MEMBRANE PROTEIN; SCAVENGER RECEPTOR BI; VITAMIN K GROUP; WARFARIN; CARRIER PROTEIN;

CELL MIGRATION; CHOLESTEROL TRANSPORT; DRUG INTERACTION; ENDOPLASMIC RETICULUM; GENE OVEREXPRESSION; HOMEOSTASIS; INTESTINE ABSORPTION; LYSOSOME; MOLECULAR DYNAMICS; MOLECULARLY TARGETED THERAPY; NIEMANN PICK DISEASE; NONHUMAN; NUTRIENT CONTENT; REVIEW; VITAMIN DEFICIENCY; VITAMIN METABOLISM; ANIMAL; HUMAN; INTESTINE; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CHOLESTEROL; HUMANS; INTESTINAL ABSORPTION; INTESTINES; MEMBRANE TRANSPORT PROTEINS; VITAMIN E; VITAMIN K;

EID: 85017029922     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.RV16007     Document Type: Review

References (78)

1. Shea MK and Holden RM: Vitamin K status and vascular calcification: evidence from observational and clinical studies. Adv Nutr, 2012; 3: 158-165
2. Bielli A, Scioli MG, Mazzaglia D, Doldo E and Orlandi A: Antioxidants and vascular health. Life Sci, 2015; 143: 209-216
3. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ and Schmitz G: The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet, 1999; 22: 347-351
4. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, Genest J, Jr. and Hayden MR: Mutations in ABC1 in Tangier disease and familial highdensity lipoprotein deficiency. Nat Genet, 1999; 22: 336-345
5. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefle P and Assmann G: Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet, 1999; 22: 352-355
6. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R and Hobbs HH: Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science, 2000; 290: 1771-1775
7. Cohen JC, Pertsemlidis A, Fahmi S, Esmail S, Vega GL, Grundy SM and Hobbs HH: Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc Natl Acad Sci U S A, 2006; 103: 1810-1815
8. Sehayek E: Genetic regulation of cholesterol absorption and plasma plant sterol levels: commonalities and differences. J Lipid Res, 2003; 44: 2030-2038
9. Altmann SW, Davis HR, Jr., Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N and Graziano MP: Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science, 2004; 303: 1201-1204
10. Mardones P, Quinones V, Amigo L, Moreno M, Miquel JF, Schwarz M, Miettinen HE, Trigatti B, Krieger M, VanPatten S, Cohen DE and Rigotti A: Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J Lipid Res, 2001; 42: 170-180
11. Bietrix F, Yan D, Nauze M, Rolland C, Bertrand-Michel J, Comera C, Schaak S, Barbaras R, Groen AK, Perret B, Terce F and Collet X: Accelerated lipid absorption in mice overexpressing intestinal SR-BI. J Biol Chem, 2006; 281: 7214-7219
12. Nguyen DV, Drover VA, Knopfel M, Dhanasekaran P, Hauser H and Phillips MC: Influence of class B scavenger receptors on cholesterol flux across the brush border membrane and intestinal absorption. J Lipid Res, 2009; 50: 2235-2244
13. Nauli AM, Nassir F, Zheng S, Yang Q, Lo CM, Vonlehmden SB, Lee D, Jandacek RJ, Abumrad NA and Tso P: CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine. Gastroenterology, 2006; 131: 1197-1207
14. Nassir F, Wilson B, Han X, Gross RW and Abumrad NA: CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine. J Biol Chem, 2007; 282: 19493-19501
15. Knopp RH, Gitter H, Truitt T, Bays H, Manion CV, Lipka LJ, LeBeaut AP, Suresh R, Yang B, Veltri EP and Ezetimibe Study G: Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur Heart J, 2003; 24: 729-741
16. Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM and Investigators I-I: Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med, 2015; 372: 2387-2397
17. Davies JP, Levy B and Ioannou YA: Evidence for a Niemann-pick C (NPC) gene family: identification and characterization of NPC1L1. Genomics, 2000; 65: 137-145
18. Liscum L and Sturley SL: Intracellular trafficking of Niemann-Pick C proteins 1 and 2: obligate components of subcellular lipid transport. Biochim Biophys Acta, 2004; 1685: 22-27
19. Loftus SK, Morris JA, Carstea ED, Gu JZ, Cummings C, Brown A, Ellison J, Ohno K, Rosenfeld MA, Tagle DA, Pentchev PG and Pavan WJ: Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science, 1997; 277: 232-235
20. Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, Nagle J, Polymeropoulos MH, Sturley SL, Ioannou YA, Higgins ME, Comly M, Cooney A, Brown A, Kaneski CR, Blanchette-Mackie EJ, Dwyer NK, Neufeld EB, Chang TY, Liscum L, Strauss JF, III, Ohno K, Zeigler M, Carmi R, Sokol J, Markie D, O’Neill RR, van Diggelen OP, Elleder M, Patterson MC, Brady RO, Vanier MT, Pentchev PG and Tagle DA: Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science, 1997; 277: 228-231
21. Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, Crona JH, Davis HR, Jr., Dean DC, Detmers PA, Graziano MP, Hughes M, Macintyre DE, Ogawa A, O’Neill K A, Iyer SP, Shevell DE, Smith MM, Tang YS, Makarewicz AM, Ujjainwalla F, Altmann SW, Chapman KT and Thornberry NA: The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci U S A, 2005; 102: 8132-8137
22. Weinglass AB, Kohler M, Schulte U, Liu J, Nketiah EO, Thomas A, Schmalhofer W, Williams B, Bildl W, McMasters DR, Dai K, Beers L, McCann ME, Kaczorowski GJ and Garcia ML: Extracellular loop C of NPC1L1 is important for binding to ezetimibe. Proc Natl Acad Sci U S A, 2008; 105: 11140-11145
23. Yamanashi Y, Takada T and Suzuki H: Niemann-Pick C1-like 1 overexpression facilitates ezetimibe-sensitive cholesterol and beta-sitosterol uptake in CaCo-2 cells. J Pharmacol Exp Ther, 2007; 320: 559-564
24. Woollett LA, Wang Y, Buckley DD, Yao L, Chin S, Granholm N, Jones PJ, Setchell KD, Tso P and Heubi JE: Micellar solubilisation of cholesterol is essential for absorption in humans. Gut, 2006; 55: 197-204
25. Cohn JS, Kamili A, Wat E, Chung RW and Tandy S: Dietary phospholipids and intestinal cholesterol absorption. Nutrients, 2010; 2: 116-127
26. Davis HR, Jr., Zhu LJ, Hoos LM, Tetzloff G, Maguire M, Liu J, Yao X, Iyer SP, Lam MH, Lund EG, Detmers PA, Graziano MP and Altmann SW: Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem, 2004; 279: 33586-33592
27. von Bergmann K, Sudhop T and Lutjohann D: Cholesterol and plant sterol absorption: recent insights. Am J Cardiol, 2005; 96: 10D-14D
28. Narushima K, Takada T, Yamanashi Y and Suzuki H: Niemann-pick C1-like 1 mediates alpha-tocopherol transport. Mol Pharmacol, 2008; 74: 42-49
29. Yamanashi Y, Takada T and Suzuki H: In-vitro characterization of the six clustered variants of NPC1L1 observed in cholesterol low absorbers. Pharmacogenet Genomics, 2009; 19: 884-892
30. Yamamoto T, Ito K, Honma M, Takada T and Suzuki H: Cholesterol-lowering effect of ezetimibe in uridine diphosphate glucuronosyltransferase 1A-deficient (Gunn) rats. Drug Metab Dispos, 2007; 35: 1455-1458
31. Takada T and Suzuki H: Molecular mechanisms of membrane transport of vitamin E. Mol Nutr Food Res, 2010; 54: 616-622
32. Abuasal BS, Sylvester PW and Kaddoumi A: Intestinal absorption of gamma-tocotrienol is mediated by Niemann-Pick C1-like 1: in situ rat intestinal perfusion studies. Drug Metab Dispos, 2010; 38: 939-945
33. Abuasal BS, Qosa H, Sylvester PW and Kaddoumi A: Comparison of the intestinal absorption and bioavailability of gamma-tocotrienol and alpha-tocopherol: in vitro, in situ and in vivo studies. Biopharm Drug Dispos, 2012; 33: 246-256
34. Kaempf-Rotzoll DE, Traber MG and Arai H: Vitamin E and transfer proteins. Curr Opin Lipidol, 2003; 14: 249-254
35. Kono N, Ohto U, Hiramatsu T, Urabe M, Uchida Y, Satow Y and Arai H: Impaired alpha-TTP-PIPs interaction underlies familial vitamin E deficiency. Science, 2013; 340: 1106-1110
36. Alexander B, Goldstein R, Landwehr G and Cook CD: Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions. J Clin Invest, 1951; 30: 596-608
37. Hougie C, Barrow EM and Graham JB: Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency. J Clin Invest, 1957; 36: 485-496
38. Booth SL and Suttie JW: Dietary intake and adequacy of vitamin K. J Nutr, 1998; 128: 785-788
39. Shearer MJ, McBurney A and Barkhan P: Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man. Vitam Horm, 1974; 32: 513-542
40. Hollander D, Rim E and Muralidhara KS: Vitamin K1 intestinal absorption in vivo: influence of luminal contents on transport. Am J Physiol, 1977; 232: E69-74
41. Merck/Schering-Plough Pharmaceutics: Zetia (ezetimibe) tablets prescribing information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021445s014lbl.pdf
42. Takada T, Yamanashi Y, Konishi K, Yamamoto T, Toyoda Y, Masuo Y, Yamamoto H and Suzuki H: NPC1L1 is a key regulator of intestinal vitamin K absorption and a modulator of warfarin therapy. Sci Transl Med, 2015; 7: 275ra223
43. Ritchie SR, Orr DW and Black PN: Severe jaundice following treatment with ezetimibe. Eur J Gastroenterol Hepatol, 2008; 20: 572-573
44. Oldenburg J, Marinova M, Muller-Reible C and Watzka M: The vitamin K cycle. Vitam Horm, 2008; 78: 35-62
45. Hashikata T, Yamaoka-Tojo M, Kakizaki R, Nemoto T, Fujiyoshi K, Namba S, Kitasato L, Hashimoto T, Ishii S, Kameda R, Shimohama T, Tojo T and Ako J: Ezetimibe enhances and stabilizes anticoagulant effect of warfarin. Heart Vessels, 2016;
46. Miettinen TA and Gylling H: Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis, 2000; 153: 241-248
47. Tremblay AJ, Lamarche B, Lemelin V, Hoos L, Benjannet S, Seidah NG, Davis HR, Jr. and Couture P: Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men. J Lipid Res, 2011; 52: 558-565
48. Acton SL, Scherer PE, Lodish HF and Krieger M: Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem, 1994; 269: 21003-21009
49. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH and Krieger M: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science, 1996; 271: 518-520
50. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER and Krieger M: Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature, 1997; 387: 414-417
51. Cai SF, Kirby RJ, Howles PN and Hui DY: Differentiation-dependent expression and localization of the class B type Ⅰ scavenger receptor in intestine. J Lipid Res, 2001; 42: 902-909
52. Hauser H, Dyer JH, Nandy A, Vega MA, Werder M, Bieliauskaite E, Weber FE, Compassi S, Gemperli A, Boffelli D, Wehrli E, Schulthess G and Phillips MC: Identification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry, 1998; 37: 17843-17850
53. Reboul E, Soayfane Z, Goncalves A, Cantiello M, Bott R, Nauze M, Terce F, Collet X and Comera C: Respective contributions of intestinal Niemann-Pick C1-like 1 and scavenger receptor class B type Ⅰ to cholesterol and tocopherol uptake: in vivo v. in vitro studies. Br J Nutr, 2012; 107: 1296-1304
54. Reboul E, Klein A, Bietrix F, Gleize B, Malezet-Desmoulins C, Schneider M, Margotat A, Lagrost L, Collet X and Borel P: Scavenger receptor class B type Ⅰ (SR-BI) is involved in vitamin E transport across the enterocyte. J Biol Chem, 2006; 281: 4739-4745
55. Goncalves A, Margier M, Roi S, Collet X, Niot I, Goupy P, Caris-Veyrat C and Reboul E: Intestinal scavenger receptors are involved in vitamin K1 absorption. J Biol Chem, 2014; 289: 30743-30752
56. Sehayek E, Ono JG, Shefer S, Nguyen LB, Wang N, Batta AK, Salen G, Smith JD, Tall AR and Breslow JL: Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption. Proc Natl Acad Sci U S A, 1998; 95: 10194-10199
57. Wiersma H, Gatti A, Nijstad N, Oude Elferink RP, Kuipers F and Tietge UJ: Scavenger receptor class B type Ⅰ mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice. Hepatology, 2009; 50: 1263-1272
58. Mardones P, Strobel P, Miranda S, Leighton F, Quinones V, Amigo L, Rozowski J, Krieger M and Rigotti A: Alphatocopherol metabolism is abnormal in scavenger receptor class B type I (SR-BI)-deficient mice. J Nutr, 2002; 132: 443-449
59. Febbraio M, Hajjar DP and Silverstein RL: CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest, 2001; 108: 785-791
60. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT and Protter AA: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem, 1993; 268: 11811-11816
61. Calvo D, Gomez-Coronado D, Suarez Y, Lasuncion MA and Vega MA: Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J Lipid Res, 1998; 39: 777-788
62. Werder M, Han CH, Wehrli E, Bimmler D, Schulthess G and Hauser H: Role of scavenger receptors SR-BI and CD36 in selective sterol uptake in the small intestine. Biochemistry, 2001; 40: 11643-11650
63. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E and Grimaldi PA: Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem, 1993; 268: 17665-17668
64. Poirier H, Degrace P, Niot I, Bernard A and Besnard P: Localization and regulation of the putative membrane fatty-acid transporter (FAT) in the small intestine. Comparison with fatty acid-binding proteins (FABP). Eur J Biochem, 1996; 238: 368-373
65. Brunham LR, Kruit JK, Iqbal J, Fievet C, Timmins JM, Pape TD, Coburn BA, Bissada N, Staels B, Groen AK, Hussain MM, Parks JS, Kuipers F and Hayden MR: Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J Clin Invest, 2006; 116: 1052-1062
66. Goncalves A, Roi S, Nowicki M, Niot I and Reboul E: Cluster-determinant 36 (CD36) impacts on vitamin E postprandial response. Mol Nutr Food Res, 2014; 58: 2297-2306
67. Nagao K, Tomioka M and Ueda K: Function and regulation of ABCA1--membrane meso-domain organization and reorganization. FEBS J, 2011; 278: 3190-3203
68. Orso E, Broccardo C, Kaminski WE, Bottcher A, Liebisch G, Drobnik W, Gotz A, Chambenoit O, Diederich W, Langmann T, Spruss T, Luciani MF, Rothe G, Lackner KJ, Chimini G and Schmitz G: Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nat Genet, 2000; 24: 192-196
69. Oram JF, Vaughan AM and Stocker R: ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol. J Biol Chem, 2001; 276: 39898-39902
70. Shichiri M, Takanezawa Y, Rotzoll DE, Yoshida Y, Kokubu T, Ueda K, Tamai H and Arai H: ATP-binding cassette transporter A1 is involved in hepatic alphatocopherol secretion. J Nutr Biochem, 2010; 21: 451-456
71. Olivier M, Bott GR, Frisdal E, Nowick M, Plengpanich W, Desmarchelier C, Roi S, Quinn CM, Gelissen I, Jessup W, Van Eck M, Guerin M, Le Goff W and Reboul E: ABCG1 is involved in vitamin E efflux. Biochim Biophys Acta, 2014; 1841: 1741-1751
72. Reboul E, Trompier D, Moussa M, Klein A, Landrier JF, Chimini G and Borel P: ATP-binding cassette transporter A1 is significantly involved in the intestinal absorption of alpha-and gamma-tocopherol but not in that of retinyl palmitate in mice. Am J Clin Nutr, 2009; 89: 177-184
73. Mulligan JD, Flowers MT, Tebon A, Bitgood JJ, Wellington C, Hayden MR and Attie AD: ABCA1 is essential for efficient basolateral cholesterol efflux during the absorption of dietary cholesterol in chickens. J Biol Chem, 2003; 278: 13356-13366
74. Hussain MM: Intestinal lipid absorption and lipoprotein formation. Curr Opin Lipidol, 2014; 25: 200-206
75. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR and Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature, 1997; 386: 78-81
76. Tomkin GH and Owens D: Investigational therapies for the treatment of atherosclerosis. Expert Opin Investig Drugs, 2014; 23: 1411-1421
77. Ajufo E and Rader DJ: Recent advances in the pharmacological management of hypercholesterolaemia. Lancet Diabetes Endocrinol, 2016; 4: 436-446
78. Kariya Y, Honma M and Suzuki H: Systems-based understanding of pharmacological responses with combinations of multidisciplinary methodologies. Biopharm Drug Dispos, 2013; 34: 489-507